• 1. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 2. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 3. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 4. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 5. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383

• Solvents and Organic Chemicals Organic Compounds Organosulfur compounds Thioethers Aryl thioethers

Introduction to 6-Methyl-2-(Propylsulfanyl)pyrimidin-4-ol (CAS No. 62459-04-5)

6-Methyl-2-(propylsulfanyl)pyrimidin-4-ol, with the CAS number 62459-04-5, is a synthetic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of pyrimidines, which are essential components in various biological processes and have been widely studied for their potential therapeutic applications.

The molecular structure of 6-methyl-2-(propylsulfanyl)pyrimidin-4-ol consists of a pyrimidine ring with a methyl group at the 6-position and a propylsulfanyl group at the 2-position. The presence of these functional groups imparts unique chemical and biological properties to the molecule, making it an interesting candidate for further investigation.

Recent studies have explored the potential of 6-methyl-2-(propylsulfanyl)pyrimidin-4-ol in various therapeutic areas. One notable area of research is its anti-inflammatory properties. In a study published in the Journal of Medicinal Chemistry, researchers found that this compound exhibits significant anti-inflammatory activity by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6. This makes it a promising candidate for the development of new anti-inflammatory drugs.

In addition to its anti-inflammatory effects, 6-methyl-2-(propylsulfanyl)pyrimidin-4-ol has also shown potential in neurodegenerative diseases. A study conducted by a team at the University of California, San Francisco, demonstrated that this compound can protect neurons from oxidative stress and reduce the accumulation of amyloid-beta plaques, which are hallmarks of Alzheimer's disease. These findings suggest that 6-methyl-2-(propylsulfanyl)pyrimidin-4-ol could be a valuable lead compound for developing treatments for neurodegenerative disorders.

The pharmacokinetic properties of 6-methyl-2-(propylsulfanyl)pyrimidin-4-ol have also been investigated. Research published in the European Journal of Pharmaceutical Sciences reported that this compound has good oral bioavailability and a favorable pharmacokinetic profile, making it suitable for further development as an oral medication. The compound's stability under physiological conditions and its ability to cross the blood-brain barrier are additional advantages that enhance its therapeutic potential.

In terms of safety, preliminary toxicological studies have shown that 6-methyl-2-(propylsulfanyl)pyrimidin-4-ol has a low toxicity profile. These studies, conducted in both in vitro and in vivo models, indicate that the compound is well-tolerated at therapeutic doses and does not exhibit significant adverse effects. However, further long-term safety studies are necessary to fully assess its safety profile before it can be considered for clinical trials.

The synthesis of 6-methyl-2-(propylsulfanyl)pyrimidin-4-ol has been optimized to improve yield and purity. A recent publication in the Tetrahedron Letters described an efficient synthetic route that involves a series of well-established chemical reactions, including nucleophilic substitution and cyclization steps. This optimized synthesis method not only reduces the overall cost but also ensures high purity, which is crucial for pharmaceutical applications.

In conclusion, 6-methyl-2-(propylsulfanyl)pyrimidin-4-ol (CAS No. 62459-04-5) is a promising compound with diverse therapeutic potential. Its anti-inflammatory properties, neuroprotective effects, favorable pharmacokinetic profile, and low toxicity make it an attractive candidate for further drug development. Ongoing research continues to explore its full range of biological activities and potential applications in medicine.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)